Global Crispr Technology Market 2022-2026

Description

List of Tables

Technavio has been monitoring the CRISPR technology market and it is poised to grow by $ 2.88 bn during 2022-2026, accelerating at a CAGR of 19.34% during the forecast period. Our report on the CRISPR technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing demand for treatment of genetic diseases, rising genome editing across biotechnology, medical, and agriculture industries, and increasing R&D activities in CRISPR technology.

The CRISPR technology market analysis includes the application segment and geographic landscape.

Technavio's CRISPR technology market is segmented as below:

By Application

Biological application
Agricultural application
Industrial application
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of CRISPR/CAS9 as one of the prime reasons driving the CRISPR technology market growth during the next few years. Also, growing demand for innovative therapeutic gene therapy techniques and increasing venture funding will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on CRISPR technology market covers the following areas:

CRISPR technology market sizing
CRISPR technology market forecast
CRISPR technology market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading CRISPR technology market vendors that include Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc. Also, the CRISPR technology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73494

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Biological application - Market size and forecast 2021-2026
Exhibit 28: Chart on Biological application - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Biological application - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Biological application - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Biological application - Year-over-year growth 2021-2026 (%)
5.4 Agricultural application - Market size and forecast 2021-2026
Exhibit 32: Chart on Agricultural application - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Agricultural application - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Agricultural application - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Agricultural application - Year-over-year growth 2021-2026 (%)
5.5 Industrial application - Market size and forecast 2021-2026
Exhibit 36: Chart on Industrial application - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Industrial application - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Industrial application - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Industrial application - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Application
Exhibit 44: Market opportunity by Application ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 78: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Danaher Corp.
Exhibit 93: Danaher Corp. - Overview
Exhibit 94: Danaher Corp. - Business segments
Exhibit 95: Danaher Corp. - Key news
Exhibit 96: Danaher Corp. - Key offerings
Exhibit 97: Danaher Corp. - Segment focus
10.4 Editas Medicine Inc.
Exhibit 98: Editas Medicine Inc. - Overview
Exhibit 99: Editas Medicine Inc. - Product / Service
Exhibit 100: Editas Medicine Inc. - Key offerings
10.5 GeneCopoeia Inc.
Exhibit 101: GeneCopoeia Inc. - Overview
Exhibit 102: GeneCopoeia Inc. - Product / Service
Exhibit 103: GeneCopoeia Inc. - Key offerings
10.6 GenScript Biotech Corp.
Exhibit 104: GenScript Biotech Corp. - Overview
Exhibit 105: GenScript Biotech Corp. - Business segments
Exhibit 106: GenScript Biotech Corp. - Key news
Exhibit 107: GenScript Biotech Corp. - Key offerings
Exhibit 108: GenScript Biotech Corp. - Segment focus
10.7 Intellia Therapeutics Inc.
Exhibit 109: Intellia Therapeutics Inc. - Overview
Exhibit 110: Intellia Therapeutics Inc. - Business segments
Exhibit 111: Intellia Therapeutics Inc. - Key offerings
Exhibit 112: Intellia Therapeutics Inc. - Segment focus
10.8 Lonza Group Ltd.
Exhibit 113: Lonza Group Ltd. - Overview
Exhibit 114: Lonza Group Ltd. - Product / Service
Exhibit 115: Lonza Group Ltd. - Key news
Exhibit 116: Lonza Group Ltd. - Key offerings
10.9 New England Biolabs Inc.
Exhibit 117: New England Biolabs Inc. - Overview
Exhibit 118: New England Biolabs Inc. - Product / Service
Exhibit 119: New England Biolabs Inc. - Key news
Exhibit 120: New England Biolabs Inc. - Key offerings
10.10 OriGene Technologies Inc.
Exhibit 121: OriGene Technologies Inc. - Overview
Exhibit 122: OriGene Technologies Inc. - Product / Service
Exhibit 123: OriGene Technologies Inc. - Key offerings
10.11 PerkinElmer Inc.
Exhibit 124: PerkinElmer Inc. - Overview
Exhibit 125: PerkinElmer Inc. - Business segments
Exhibit 126: PerkinElmer Inc. - Key news
Exhibit 127: PerkinElmer Inc. - Key offerings
Exhibit 128: PerkinElmer Inc. - Segment focus
10.12 Thermo Fisher Scientific Inc.
Exhibit 129: Thermo Fisher Scientific Inc. - Overview
Exhibit 130: Thermo Fisher Scientific Inc. - Business segments
Exhibit 131: Thermo Fisher Scientific Inc. - Key news
Exhibit 132: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 133: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 134: Inclusions checklist
Exhibit 135: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 136: Currency conversion rates for US$
11.4 Research methodology
Exhibit 137: Research methodology
Exhibit 138: Validation techniques employed for market sizing
Exhibit 139: Information sources
11.5 List of abbreviations
Exhibit 140: List of abbreviations